Showing 1 to 12 of 27 results
Aspirin Reduces Colorectal Cancer Recurrence Risk
A Swedish study found that colorectal cancer patients with specific genetic mutations taking daily low-dose aspirin after surgery were 55% less likely to experience cancer recurrence within three years compared to a placebo group.
Aspirin Reduces Colorectal Cancer Recurrence Risk
A Swedish study found that colorectal cancer patients with specific genetic mutations taking daily low-dose aspirin after surgery were 55% less likely to experience cancer recurrence within three years compared to a placebo group.
Progress
36% Bias Score
Promising Results for Experimental Cancer Vaccine Targeting KRAS Mutations
An experimental cancer vaccine, ELI-002, designed to target KRAS mutations, shows promising results in a small trial with 25 patients, increasing the time before cancer recurrence in those with pancreatic cancer by an average of 15 months post-surgery and chemotherapy.
Promising Results for Experimental Cancer Vaccine Targeting KRAS Mutations
An experimental cancer vaccine, ELI-002, designed to target KRAS mutations, shows promising results in a small trial with 25 patients, increasing the time before cancer recurrence in those with pancreatic cancer by an average of 15 months post-surgery and chemotherapy.
Progress
40% Bias Score
Study Links Small Amounts of Processed Meats, Sugary Drinks, Trans Fats to Increased Disease Risk
A new study in Nature Medicine reveals a strong link between small amounts of processed meat, sugary drinks, and trans fats and increased risks of type 2 diabetes, heart disease, and colorectal cancer; researchers analyzed data from over 60 previous studies.
Study Links Small Amounts of Processed Meats, Sugary Drinks, Trans Fats to Increased Disease Risk
A new study in Nature Medicine reveals a strong link between small amounts of processed meat, sugary drinks, and trans fats and increased risks of type 2 diabetes, heart disease, and colorectal cancer; researchers analyzed data from over 60 previous studies.
Progress
24% Bias Score
Three-Drug Combo Doubles Survival Time for Aggressive Colorectal Cancer
A late-stage trial revealed that a three-drug combination—including a standard chemotherapy drug, cetuximab, and Braftovi—doubled the survival time for colorectal cancer patients with the BRAF V600E mutation to approximately 30 months, compared to 15 months with standard chemotherapy, offering a sig...
Three-Drug Combo Doubles Survival Time for Aggressive Colorectal Cancer
A late-stage trial revealed that a three-drug combination—including a standard chemotherapy drug, cetuximab, and Braftovi—doubled the survival time for colorectal cancer patients with the BRAF V600E mutation to approximately 30 months, compared to 15 months with standard chemotherapy, offering a sig...
Progress
44% Bias Score
BOP Fails Inmate Colorectal Cancer Screenings, Leading to Deaths
A Department of Justice Inspector General report revealed the Federal Bureau of Prisons' (BOP) failures in colorectal cancer screenings and follow-up care for inmates, resulting in delayed diagnoses and deaths; systemic issues include staffing shortages, budgetary problems, and electronic medical re...
BOP Fails Inmate Colorectal Cancer Screenings, Leading to Deaths
A Department of Justice Inspector General report revealed the Federal Bureau of Prisons' (BOP) failures in colorectal cancer screenings and follow-up care for inmates, resulting in delayed diagnoses and deaths; systemic issues include staffing shortages, budgetary problems, and electronic medical re...
Progress
44% Bias Score
Rise in Colorectal Cancer Among Younger Dutch Adults
Colorectal cancer diagnoses among 15- to 49-year-olds in the Netherlands increased by 50 percent from 1998 to 2023, reaching 9.5 cases per 100,000 in 2023, projected to rise further to 762 annual cases by 2035; research suggests lifestyle and environmental factors play a significant role, highlighti...
Rise in Colorectal Cancer Among Younger Dutch Adults
Colorectal cancer diagnoses among 15- to 49-year-olds in the Netherlands increased by 50 percent from 1998 to 2023, reaching 9.5 cases per 100,000 in 2023, projected to rise further to 762 annual cases by 2035; research suggests lifestyle and environmental factors play a significant role, highlighti...
Progress
28% Bias Score
Postpartum Colon Cancer Death Highlights Early-Onset Diagnosis Challenges
A 37-year-old Chinese woman died from colorectal squamous cell carcinoma (SCC), a rare and aggressive cancer diagnosed one month after childbirth, highlighting challenges in diagnosing postpartum cancers and the rising incidence of early-onset colorectal cancer.
Postpartum Colon Cancer Death Highlights Early-Onset Diagnosis Challenges
A 37-year-old Chinese woman died from colorectal squamous cell carcinoma (SCC), a rare and aggressive cancer diagnosed one month after childbirth, highlighting challenges in diagnosing postpartum cancers and the rising incidence of early-onset colorectal cancer.
Progress
36% Bias Score
Misdiagnosis Delays Stage Four Colon Cancer Diagnosis in Young Adult
Rylie Toomey, 27, was misdiagnosed with constipation multiple times before a stage four colon cancer diagnosis revealed a perforated bowel; her case highlights a rising trend of colorectal cancer in young adults, despite healthy lifestyles, potentially linked to E. coli exposure or marijuana use.
Misdiagnosis Delays Stage Four Colon Cancer Diagnosis in Young Adult
Rylie Toomey, 27, was misdiagnosed with constipation multiple times before a stage four colon cancer diagnosis revealed a perforated bowel; her case highlights a rising trend of colorectal cancer in young adults, despite healthy lifestyles, potentially linked to E. coli exposure or marijuana use.
Progress
40% Bias Score
Exercise, Diet, and New Drug Show Promise in Combating Colorectal Cancer
New studies show that regular exercise and an anti-inflammatory diet significantly improve survival rates for colorectal cancer patients, while a new drug, Braftovi, doubled survival time for patients with an aggressive form of the disease in clinical trials.
Exercise, Diet, and New Drug Show Promise in Combating Colorectal Cancer
New studies show that regular exercise and an anti-inflammatory diet significantly improve survival rates for colorectal cancer patients, while a new drug, Braftovi, doubled survival time for patients with an aggressive form of the disease in clinical trials.
Progress
16% Bias Score
Alcohol and Smoking Synergistically Increase Early-Onset Colorectal Cancer Risk
A German study found that daily alcohol consumption increases early-onset colorectal cancer risk by 39 percent, while 100 cigarettes in a lifetime increase the risk by 59 percent, highlighting the synergistic effect of both habits.
Alcohol and Smoking Synergistically Increase Early-Onset Colorectal Cancer Risk
A German study found that daily alcohol consumption increases early-onset colorectal cancer risk by 39 percent, while 100 cigarettes in a lifetime increase the risk by 59 percent, highlighting the synergistic effect of both habits.
Progress
44% Bias Score
GLP-1 Agonists Show Potential for Reducing Obesity-Related Cancer Risk
A new study of 170,030 obese and diabetic adults in the US found that GLP-1 receptor agonists (Ozempic, Wegovy, etc.) may modestly reduce the risk of 14 obesity-related cancers and all-cause mortality, especially in women, compared to DDP-4 inhibitors.
GLP-1 Agonists Show Potential for Reducing Obesity-Related Cancer Risk
A new study of 170,030 obese and diabetic adults in the US found that GLP-1 receptor agonists (Ozempic, Wegovy, etc.) may modestly reduce the risk of 14 obesity-related cancers and all-cause mortality, especially in women, compared to DDP-4 inhibitors.
Progress
44% Bias Score
Cooking Methods, Intestinal Health, and Colorectal Cancer Risk
A Spanish study reveals high-temperature cooking creates potentially carcinogenic compounds, particularly PhIP in meat and fish, increasing intestinal damage and colorectal cancer risk; however, fiber intake reduces this risk.
Cooking Methods, Intestinal Health, and Colorectal Cancer Risk
A Spanish study reveals high-temperature cooking creates potentially carcinogenic compounds, particularly PhIP in meat and fish, increasing intestinal damage and colorectal cancer risk; however, fiber intake reduces this risk.
Progress
36% Bias Score
Showing 1 to 12 of 27 results